Hidden Traffic Podcast: Trade Law and Human Rights with Dean Pinkert
Hot Topics in International Trade. Braumiller Law Group Partner & Founder Adrienne Braumiller joins Vp of Marketing Bob Brewer for an Update on Forced Labor
Braumiller Law Group Help With China Imports
Third Party Ethical Audits
ESG: How Supply Chain Contracts Affect Human Rights - On Record PR
Hidden Traffic Podcast - The UN’s Stance on Business and Human Rights with Nate Lankford
Environmental Defender Romina Picolotti on Climate Justice and Human Rights
The Compliance Kitchen - OFAC issues Ethiopia Sanctions Regs
The ESG Report - Compliance and Human Rights Strategy
Season Two Trailer
Fraud Eats Strategy - Human Trafficking is Everyone’s Problem: Steps that Organizations Can Take to Disrupt Human Trafficking
2021 Employment Law Update: Part 12 – Tips and Trends for 2021 and 2022
WorldSmart: How Businesses Can Mitigate Risk of Forced Labor in Their Supply Chains
Leaders Moving Business Forward with Alphonso David of the Human Rights Campaign
JONES DAY TALKS®: Navigating Sanctions and Export Controls: A Guide for EMEA Businesses
Framing the American Past to Better Understand Women and Gender History with UC Davis Professors Ellen Hartigan -O’Conner and Lisa Materson: On Record PR
Book Discussion with Brittany Barnett, Author of A Knock at Midnight, and Tanya Eiserer (WFAA-TV)
Altering the Course of History for Women and Girls Around the World, with Latanya Mapp Frett, President and CEO of Global Fund for Women: On Record PR
Coronavirus in the Workplace
BLACK HISTORY MONTH | ELLA BAKER & MARY MCLEOD BETHUNE
Welcome to the April 2024 issue of “As the (Customs and Trade) World Turns,” our monthly newsletter where we compile essential updates from the customs and trade world over the past month. We bring you the most recent and...more
Earlier this month, the U.S. Food and Drug Administration (“FDA”) issued new guidance (“Guidance”) for sponsors, investigators, and institutional review boards (“IRBs”) regarding how recent changes to the Federal Policy for...more
On October 12, FDA published guidance for sponsors, investigators, and IRBs titled “Impact of Certain Provisions of the Revised Common Rule on FDA-Regulated Clinical Investigations.” ...more
As July comes to an end, the Food and Drug Administration (FDA or agency) has issued a new guidance document for “immediate implementation” entitled “IRB Waiver or Alteration of Informed Consent for Clinical Investigations...more
On January 19, 2017, sixteen federal agencies, including the Departments of Health and Human Services and Labor, published the first revision to the federal regulations governing the protection of human subjects participating...more
The Final Rule published by the US Department of Health and Human Services on January 18, 2017, largely avoids major modifications to the Common Rule. However, it specifically addresses creation of biospecimen and data...more
Proposals are Intended to Enhance Protections for Higher Risk Clinical Research and Privacy Safeguards, including Uses of Biospecimens and Identifiable Private Information - On September 8, 2015, the Department of Health...more
On September 2, 2015, HHS issued the long-awaited Notice of Proposed Rulemaking (NPRM) on revisions to the rules governing federally-funded research involving individuals, commonly referred to as the Common Rule (Subpart A of...more
The U.S. Department of Health and Human Services (“HHS”) and fifteen other Federal Departments and Agencies have announced a proposal to update the Federal Policy for the Protection of Human Subjects known as the “Common...more